Who Paid My Doc
Lemtrada
Biological Neurology
NDC 58468-0200-1
General payments
$331,112
Research payments
$3,758,511
Through program year 2025, $331,112 in general payments and $3,758,511 in research payments were reported against Lemtrada (Neurology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
13 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $184 | 2 |
| 2025 | Research | $111,384 | 40 |
| 2024 | General | $3,716 | 26 |
| 2024 | Research | $105,217 | 60 |
| 2023 | General | $14,097 | 110 |
| 2023 | Research | $300,688 | 128 |
| 2022 | General | $14,108 | 85 |
| 2022 | Research | $342,381 | 193 |
| 2021 | General | $78,026 | 374 |
| 2021 | Research | $1,675,397 | 272 |
| 2020 | General | $198,541 | 1,784 |
| 2020 | Research | $1,223,444 | 410 |
| 2019 | General | $22,440 | 12 |
Breakdown
Each share is of general payments naming this product in 2025.
Each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
Each share is of general payments naming this product in 2025 where a state was reported.
Records
2,393 general · 1,103 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.